A versus B versus C versus no treatment: A longed-for study offers cloudy results.Dr. Omar Khan and a research team at Wayne State University Wayne State University, at Detroit, Mich.; state supported; coeducational; established 1956 as a successor to Wayne Univ. (formed 1934 by a merger of five city colleges). in Detroit reported results from a clinical trial comparing Avonex, Betaseron, Copaxone, and no treatment at all in people with relapsing-remitting MS. Only a few details of the study have been made public, and nothing has yet been published. Dr. Khan's study followed 156 people for more than a year comparing results in the 4 groups. In a poster session A poster session is the juried presentation of research information by representatives of several research teams at a congress or conference with an academic or professional focus. These are particularly prominent at scientific conferences such as medical congresses. at the annual meeting of the American Neurological Association The American Neurological Association, is a professional society with a mission of educating neurologists and physicians as well as increasing knowledge and enhancing treatment of diseases of the nervous system.[1] It was founded in June of 1875. in Seattle, Washington, in October, Dr. Khan indicated that Betaseron and Copaxone appear to produce "improvement in disability scores" when compared to the "no treatment" group while Avonex did not. No comparison of the relapse rates among the 3 drugs, or between any one drug and "no treatment", was reported. Caution advised As soon as the 3 ABC ABC in full American Broadcasting Co. Major U.S. television network. It began when the expanding national radio network NBC split into the separate Red and Blue networks in 1928. drugs became available, people have been calling for head-to-head tests. However, this study was not blinded or randomized ran·dom·ize tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es To make random in arrangement, especially in order to control the variables in an experiment. , according to the standards of the most respected clinical trials. All participants were told about the 4 options and allowed to choose their treatment. The healthcare professionals managing the trial knew what the choice was. "We look forward to an opportunity to review the full study," said Dr. Stanley van den Noort, chairman of the Society's Medical Advisory Board. "In the meantime Adv. 1. in the meantime - during the intervening time; "meanwhile I will not think about the problem"; "meantime he was attentive to his other interests"; "in the meantime the police were notified" meantime, meanwhile , we stand by our Disease Management Consensus Statement. The 3 drugs can be considered equally effective. People with relapsing-remitting MS can be reassured that an A, B, or C drug is beneficial." |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion